| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 209 |
| 1 | BEVACIZUMAB | 198 |
| 2 | CARBOPLATIN | 188 |
| 3 | METHOTREXATE SODIUM | 172 |
| 4 | METHOTREXATE | 163 |
| 5 | TRASTUZUMAB | 163 |
| 6 | PREDNISONE | 160 |
| 7 | OMEPRAZOLE MAGNESIUM | 147 |
| 8 | PACLITAXEL | 138 |
| 9 | ASPIRIN | 133 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ISHANCARE HEMORRHOID CREAM | 8 | 0.0184 |
| 1 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 3 | 0.0123 |
| 2 | BENZOCAINE AND MENTHOL | 3 | 0.0115 |
| 3 | MINERAL OIL | 13 | 0.0092 |
| 4 | ERDAFITINIB | 10 | 0.0082 |
| 5 | NERATINIB | 17 | 0.0074 |
| 6 | DIMETICONE | 2 | 0.0071 |
| 7 | L-TRYPTOPHAN | 3 | 0.0071 |
| 8 | MIRVETUXIMAB SORAVTANSINE | 10 | 0.0061 |
| 9 | WHITE PETROLATUM | 8 | 0.0057 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 406 |
| 1 | Platinum-based Drug [EPC] | 331 |
| 2 | Kinase Inhibitor [EPC] | 310 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 290 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 278 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 220 |
| 6 | Microtubule Inhibitor [EPC] | 208 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 198 |
| 8 | Aromatase Inhibitor [EPC] | 190 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 189 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Stimulating Hormone [EPC] | 4 | 0.0039 |
| 1 | Vasoconstrictor [EPC] | 1 | 0.0034 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0029 |
| 3 | Actinomycin [EPC] | 6 | 0.0027 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 184 | 0.0024 |
| 5 | Estrogen Receptor Antagonist [EPC] | 88 | 0.0022 |
| 6 | Aromatase Inhibitor [EPC] | 190 | 0.0017 |
| 7 | Blood Viscosity Reducer [EPC] | 7 | 0.0016 |
| 8 | Interleukin-6 Antagonist [EPC] | 1 | 0.0016 |
| 9 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0015 |